MedPath

Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate

Not Applicable
Conditions
Snoring
Apnea
Registration Number
NCT00804037
Lead Sponsor
University of Sao Paulo
Brief Summary

SUMMARY INTRODUCTION: among various treatments for patients with primary snoring, upper airway resistance syndrome (UARS) and obstructive sleep apnea syndrome (OSAS), the injection snoreplasty arose as a promising alternative in some selected cases.

OBJECTIVE: to investigate the efficacy and tolerance of injection snoreplasty comparing Ethanol and Ethanolamine Oleate.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Snoring
  • RDI < 15 /h
Exclusion Criteria
  • BMI > 35

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Snoring3 months after treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of São Paulo

🇧🇷

São Paulo, SP, Brazil

University of São Paulo
🇧🇷São Paulo, SP, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.